국내학술대회

  • 학술행사
  • 국내학술대회

대한부인종양학회 학술대회

<<2022년 제37차 학술대회>>

일시 : 2022년 4월 15일(금)
장소 : 제주 메종글래드호텔

강의록 다운로드

08:30-08:50 Registration 이대우 (대한부인종양학회 사무총장)
Convention hall
08:50-09:00 개회사 및 명예회원증 수여 김영태 (대한부인종양학회 회장)
Session I-1 Keynote Lecture I 좌장: 유희석 (아주의대) 김영탁 (울산의대)
09:00-09:25 Recurrent ovarian cancer: when does surgery make a difference? Ginger J. Gardner (Memorial Sloan Kettering Cancer Center, USA)
Designated discussion 임가원 (동국의대)
09:25-09:50 Overcoming homologous recombination proffciency in ovarian cancer Aikou Okamoto (Jikei University, Japan)
Designated discussion 최윤진 (가톨릭의대)
Session I-2 Keynote Lecture II 좌장: 김재원 (서울의대) 이철민 (차의대)
09:50-10:15 Recent progress of precision medicine in ovarian cancer Andreas du Bois (Kliniken Essen-Mitte, Germany
Designated discussion 박수진 (서울의대)
10:15-10:40 Bio- and GenomeBank Denmark (RBGB) including the danish cancerbiobank Estrid Hoegdall (University of Copenhagen, Denmark)
Designated discussion 유상영 (원자력병원)
10:40-11:00 Coffee break
Session II-1 Plenary session I 좌장: 김승철 (이화의대) 조치흠 (계명의대)
11:00-11:10 Lymphadenectomy in clinically early epitheLial ovarian cancer and survival analysis: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion (GORILLA) group (GORILLA-3002) 양은정 (건국의대)
11:10-11:20 Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion (GORILLA) group (GORILLA-3001)) 손주혁 (아주의대)
11:20-11:30 Selection Criteria for Omitting interval debulking suRgery after nEoadjuvant chemotherapy for advanced high-grade serous carcinoma of the ovary: KGOG OVsurg-2016/SCORE study 박수진 (서울의대)
11:30-11:40 Designated discussion 조한별 (연세의대) 이대형 (영남의대) 이원무 (한양의대)
Session II-2 Plenary session II 좌장: 배덕수 (을지의대) 최중섭 (한양의대)
11:40-11:50 A nomogram to predict anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer 김지현 (국립암센터)
11:50-12:00 Optimal management of platinum-sensitive relapsed ovarian clear cell carcinoma: A multi-center study in Korea 김세익 (서울의대)
12:00-12:10 Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: A Korea multicenter cohort study 심승혁 (건국의대)
12:10-12:20 Designated discussion 이선주 (건국의대) 신진우 (가천의대) 남은지 (연세의대)
Luncheon symposium 좌장: 남주현 (울산의대) 김용범 (서울의대)
12:20-12:40 A new powder-type hemostatic agent in gynecologic oncologic surgical procedures 박성택 (한림의대)
12:40-13:00 The incorporation of HPV testing for cervical cancer screening: The What, Why, and How? Warner K. Huh (University of Alabama at Birmingham, USA)
13:00-13:30 Lunch
Symposium I- Convention hall
Session Ⅲ-1 Focused plenary session Ⅰ 좌장: 김재욱 (연세의대) 남궁성은 (가톨릭의대)
13:30-13:40 Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer 김기동 (서울의대)
13:40-13:50 Ten-year survival for patients with epithelial ovarian cancer treated with consolidation hyperthermic intraperitoneal chemotherapy 유지근 (가톨릭의대)
13:50-14:00 Genome-based molecular classification and clinicopathological features in korean patients 한경희 (차의대)
14:00-14:10 Anticancer effect of fenbendazole according to drug delivery mode in ovarian cancer models 장지선 (성균관의대)
14:10-14:20 Open versus minimally invasive radical hysterectomy in early-stage cervical cancer with usual type adenocarcinoma and adenosquamous carcinoma: A two-center retrospective study with central pathology review 김여래 (서울의대)
Session Ⅲ-2 Focused plenary session Ⅱ 좌장: 강순범 (서울의대) 허수영 (가톨릭의대)
14:20-14:30 Development and validation of a prediction model for successful complete cytoreduction at primary cytoreductive surgery for advanced ovarian cancer by integrating of 18F-FDG PET/CT parameters and CA-125 김준환 (서울의대)
14:30-14:40 Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer 전정은 (성균관의대)
14:40-14:50 Evaluation of anti-cancer ecacy of siRNA targeting HPV16 E6 and E7 combined with cisplatin in cervical cancer cells xenograft mouse model 박민정 (울산의대)
14:50-15:00 Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancer 권병수 (경희의대)
15:00-15:10 Anti-cancer activity of cabozatinib and temozolomide and their ecacy for uterine leiomyosarcoma in a mouse xenograft mode 노준호 (성균관의대)
15:10-15:30 Coffee break
Session Ⅳ 부인암 수술동의서 개발 및 HPV 연구용역사업 보고 좌장: 이종민 (경희의대) 이재관 (고려의대)
15:30-15:45 의사의 설명의무와 의료분쟁  현두륜 변호사 (법무법인 세승)
15:45-15:55 수술동의서 소개 심승혁 (건국의대)
15:55-16:05 Discussion 장하균 (고려의대)
16:05-16:20 국가암검진 자궁경부암 선별검사에서 인유두종바이러스 DNA검사의 비용-효과 분석 김현규 (연세의대 예방의학교실)
16:20-16:30 Discussion 정대훈 (인제의대)
Symposium II- Crystal hall 1
Session Ⅲ-3 Focused plenary session Ⅲ 좌장: 김병기 (성균관의대) 성석주 (차의대)
13:30-13:40 Effect of post-operative hormone replacement therapy on survival in women with ovarian cancer 이방현 (인하의대)
13:40-13:50 Efficacy and potential pitfalls of pre-operative PET-CT in endometrial cancer patients undergoing one-step and two-step sentinel lymph node mapping: Is PET-CT negative really node negative? 김유나 (연세의대)
13:50-14:00 Survival outcomes from laparoscopic radical hysterectomy in conizationskipped, stage IB1 cervical cancer 임현지 (서울의대)
14:00-14:10 Role of glycine decarboxylase in chemo-resistant ovarian cancer cells 이승미 (계명의대)
14:10-14:20 Is minimally invasive surgery safe for cervical cancer patients with a diameter of less than 2 cm? 공태욱 (아주의대)
Session Ⅲ-4 Focused plenary session Ⅳ 좌장: 김용만 (울산의대) 김태진 (건국의대)
14:20-14:30 Incidence of cervical intraepithelial neoplasia in republic of korea: A nationwide cross-sectional study 2009-2018 경민선 (한림의대)
14:30-14:40 A phase II trial of docetaxel/cisplatin chemotherapy followed by pelvic radiation therapy in patients with high-risk endometrial carcinoma after staging surgery 조윤정 (울산의대)
14:40-14:50 Role of klotho as a modulator of oxidative stress associated with ovarian tissue cryopreservation 이상훈 (고려의대)
14:50-15:00 Comparison of outcome of sentinel node biopsy vs. Lymphadenectomy in endometrial cancer: A propensity-matched data 이다혜 (연세의대)
15:00-15:10 Enhanced susceptibility to cervical cancer in korean women with elevated serum gamma-glutamyltransferase levels: A nationwide population-based cohort study 설애란 (고려의대)
15:10-15:30 Coffee break
Session Ⅴ Biomarkers and application in precision medicine for gynecologic cancers 좌장: 유종우 (국립암센터 병리학교실) 박노현 (서울의대) 김재훈 (연세의대)
15:30-15:50 Biomarkers for molecular classification of endometrial cancer 김현수 (성균관의대 병리학교실)
15:50-16:10 Biomarkers and HRD for ovarian cancer 김효진 (서울의대 병리학교실)
16:10-16:30 Biomarkers for uterine sarcoma and rare tumors 조화진 (인제의대 병리학교실)
Symposium Ⅲ- Crystal hall 2
Session Ⅲ-5 Focused plenary session Ⅴ 좌장: 남계현 (순천향의대) 장석준 (아주의대)
13:30-13:40 Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by magnetic resonance-based radiomics 송희경 (가톨릭의대)
13:40-13:50 Trends in incidence and survival of patients with vulvar cancer in an asian country: analysis of the korean central cancer registry 1999–2018 조성실 (한양의대)
13:50-14:00 Recurrence prediction of endometrial cancer patients with various machine learning technique 신원교 (충남의대)
14:00-14:10 Anti-tumor effects of lenvatinib plus anti-PD-1 in syngeneic murine cervical cancer models 강지식 (울산의대)
14:10-14:20 The expression of HOXA-AS3 induces tumor progression through the epithelialmesenchymal transition pathway in epithelial ovarian cancer 어경진 (연세의대)
Session Ⅲ-6 Focused plenary session Ⅵ 좌장: 김기형 (부산의대) 박철민 (제주의대)
14:20-14:30 Clinical characteristics and desensitization protocol of chemotherapy-induced hypersensitivity reactions in patients with gynecologic cancer 김승호 (울산의대)
14:30-14:40 Impact of neoadjuvant chemotherapy cycles in patients with advanced epithelial ovarian cancer: meta-analysis and systemic review 조현웅 (고려의대)
14:40-14:50 Identification of immune-related biomarkers associated with BRCA mutations in epithelial ovarian cancer 김효선 (연세의대)
14:50-15:00 Lymphedema in cervical cancer survivor: a nationwide cohort study 이수정 (가톨릭의대)
15:00-15:10 Multiplexed immunohistochemistry for immune profiling in cervical cancer according to tumor budding status 김종미 (경북의대)
15:10-15:30 Coffee break
Session Ⅲ-7 Focused plenary session VII 좌장: 이정원 (성균관의대) 김상운 (연세의대)
15:30-15:40 DKK3, downregulated in ovarian cancer, enhanced paclitaxel susceptibility by inhibiting the P-glycoprotein 이은주 (중앙의대)
15:40-15:50 Effect of quality control program in surgical management of early cervical cancer 김보라 (이화의대)
15:50-16:00 CD8α+ dendritic cells enhance the antitumor and immune activities against syngeneic and orthotopic murine ovarian cancer models 남소현 (울산의대)
16:00-16:10 Robotic single-site radical hysterectomy for early cervical cancer: A single center experience of 5 years 장태규 (계명의대)
16:10-16:20 Prediction of lymphovascular space invasion in patients with endometrial cancer 김상일 (가톨릭의대)
16:20-16:30 Neutrophil–lymphocyte and platelet–lymphocyte ratios in preoperative differential diagnosis of benign, borderline, and malignant ovarian tumors 유정민 (대구가톨릭의대)
Convention hall
Session Ⅵ Tumor board 좌장: 김대연 (울산의대) 이택상 (서울의대)
16:40-17:20 Endometrial cancer with suspicious lymph node metastasis 박정열 (울산의대)
Panel discussion 김태훈 (서울의대) 이유영 (성균관의대) 김미경 (이화의대)
17:20 폐회사 김영태 (대한부인종양학회 회장)
18:30 신풍호월학술상 & JGO Best Paper & Reviewer Award 시상 및 만찬

연도별 학술행사

제26차 대한부인종양학회 추계심포지엄 E-Conference

제26차 대한부인종양학회 추계심포지엄 E-Conference
일시 : 2020년 10월 31일(토)

강의록 다운로드

통합 program
통합 Program
사회: 서동훈 (대한부인종양학회 사무총장)
08:30-08:40 Opening Remarks 김승철 (대한부인종양학회 회장)
Session I-1제4회 부인종양의학상 시상식 및 발표 좌장: 배덕수 (성균관의대)
김영탁 (울산의대)
08:40-08:50 부인종양의학상 학술대상 수상자 논문 발표
08:50-09:00 부인종양의학상 젊은의학자상 수상자 논문 발표
Session I-2The Best Real-World Practice 좌장: 김영태 (연세의대)
김재원 (서울의대)
09:00-09:20 The best type of PARPi for the best time in the management of ovarian cancer 이신화 (울산의대)
09:20-09:40 The best type of PD1 inhibitor for the best time in the management of cervical cancer 이원무 (한양의대)
09:40-10:00 PD1 inhibitor with/without multiple kinase inhibitor for the treatment of endometrial cancer 이유영 (성균관의대)
10:00-10:20 Which phase II/III RCTs in ovarian cancer will be finalized in 5 year? 유헌종 (충남의대)
10:20-10:30 Discussion
Session I-3Clinical Studies Update in Gynecologic Cancer 좌장: 남계현 (순천향의대)
이종민 (경희의대)
10:30-10:50 Secondary cytoreductive surgery in recurrent epithelial ovarian cancer 이산희 (연세원주의대)
10:50-11:10 Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer 임명철 (국립암센터)
11:10-11:30 ADC(Antibody-Drug Conjugate) in management of ovarian cancer 조한별 (연세의대)
11:30-11:50 Novel discoveries in endometrial cancer: are we making progress? 이성종 (가톨릭의대)
11:50-12:10 Screening for lynch syndrome in endometrial cancer patients 김미경 (이화의대)
12:10-12:20 Discussion
Luncheon Symposium 좌장: 김기형 (부산의대)
12:20-12:40 Rationale for earlier intervention with PARP inhibitor and importance of personalized medicine in ovarian cancer 김기동 (서울의대)
12:40-13:40 Lunch
학술 program
학술 Program
사회: 서동훈 (대한부인종양학회 사무총장)
Session II-1International Issues
13:40-14:00 Quality control of surgery in advanced epithelial ovarian cancer 좌장: 장석준 (아주의대)
Christina Fotopoulou
(Imperial College London, UK)
14:00-14:05 Discussion 김희승 (서울의대)
14:05-14:25 Current and future considerations for the use of checkpoint inhibitors in gynecologic cancers 좌장: 강석범 (국립암센터)
David O'Malley
(The Ohio State University, USA)
14:25-14:30 Discussion 어경진 (연세의대)
14:30-14:45 An introduction to NUWA-National gynecological oncology research and patient management platform 좌장: 이택상(서울의대)
Qinglei Gao
(Huazhong University, China)
14:45-14:50 Discussion 김세익 (서울의대)
Session II-2Special Lectures 좌장: 허수영 (가톨릭의대)
이재관 (고려의대)
14:50-15:10 9가 자궁경부암 예방백신 허가 사항 - 진료권고안 업데이트 민경진 (고려의대)
15:10-15:30 Future treatment strategy based on PARPi frontline ovaian cancer Antonio González-MartÍn
(ClÍnica Universidad de Navarra, Spain)
15:30-15:50 Patient blood management as a standard of care 이정재 (순천향의대)
15:50-16:00 Perioperative use of IV iron in gynecologic cancer patients (증례발표) 서동훈 (서울의대)
16:00-16:30 Clinical impact of febrile neutropenia with ovarian cancer by pegfilgrastim 최철훈 (성균관의대)
16:30-16:40 Discussion
16:40 Closing Remarks
16:50-17:10 정기총회(ZOOM Meeting)
학술 program/간호분과 program
간호분과 Program
사회: 문혜성 (이대목동병원)
13:30-13:40 Opening Remarks 노주희
(대한부인종양학회 간호분과소위원장)
Nursing Session I-1Key Updates in Hereditary Gynecologic Cancer 좌장: 노주희 (전북대학교 간호대학)
이정원 (성균관의대)
13:40-14:00 Recent clinical trial outcome based on the hereditary predisposition of gynecologic cancer 신소진 (계명의대)
14:00-14:20 Clinical significance and reclassification of PV/LPV/VUS of BRCA 1/2 남은지 (연세의대)
14:20-14:40 What should we know about real-world genetic counseling of hereditary gynecologic cancer? 정고운 (국립암센터)
14:40-14:50 Discussion
Nursing Session I-2New Trend in Genetic Care in Gynecologic Oncology 좌장: 노기옥 (건양대학교 간호대학)
김태진 (건국의대)
14:50-15:10 Genome & health record 홍경원 (테라젠이텍스)
15:10-15:30 New treatment for hereditary gynecologic cancer 유선영 (서울아산병원)
15:30-15:50 Knowledge and anxiety in hereditary ovarian cancer patients 이상희 (국립암센터)
15:50-16:00 Discussion

연도별 학술행사

2021년 JGO Workshop
Date: April 18(Sun), 2021 / Venue: Seoul Dragon City, 3F Shilla Room

TOP